U.S. Health Care REITs Stock News

Recent Performance Snapshot Ollie's Bargain Outlet Holdings (OLLI) has drawn investor attention after a mixed stretch for the stock, with gains over the past week and month but declines over the past 3 months and year. At a recent close of US$83.25 and a market value of about US$5.1b, the company combines discount retail positioning with reported annual revenue of US$2.7b and net income of US$249.4m. See our latest analysis for Ollie's Bargain Outlet Holdings. That backdrop comes after a year...

Factorial Energy (FAC) has quickly drawn attention after completing its SPAC merger, debuting on Nasdaq, and integrating its solid-state battery into a Stellantis Dodge Charger Daytona for road testing in North America. See our latest analysis for Factorial Energy. Those governance changes, the Nasdaq listing and inclusion in the Nasdaq Composite have come alongside sharp price swings, with a 30 day share price return of 47.69% and a 90 day share price return of 49.34%, despite a 1 day...

Earlier this month, Shopify expanded its share repurchase authorization by US$3.00 billion to a total of US$5.00 billion, after completing US$1.45 billion of buybacks representing 12,297,571 shares or 0.94% of its share count. Management framed the enlarged program as a way to balance ongoing investment in merchant-focused product development and AI initiatives with returning capital to shareholders, signaling confidence in the company’s business durability and cash generation. We’ll now...

In early June 2026, Super Group (SGHC) declared a regular cash dividend of US$0.05 per share, payable on June 30 to shareholders of record on June 23, bringing total 2026 dividends declared so far to US$0.10 per share. At the same time, Super Group’s exposure to major World Cup betting markets such as South Africa, Germany, the U.K. and Spain has brought fresh focus to how global tournaments can influence its betting and gaming activity. We’ll now examine how Super Group’s World Cup exposure...

PVH Corp. recently reported first-quarter 2026 results, with sales rising to US$2,025.1 million and net income improving to US$88 million, alongside diluted earnings per share from continuing operations of US$1.90. At the same time, PVH projected roughly flat full-year 2026 revenue and a 3% to 4% second-quarter revenue decline, underscoring how conflict-related pressure in EMEA is offsetting momentum in its direct-to-consumer and e-commerce channels. Next, we'll examine how PVH’s stronger...

This article considers whether Bank of America at US$56.02 is priced for opportunity or already reflects much of its potential, and walks through what the current share price might be indicating about value. The stock has returned 4.1% over the past week, 12.4% over the last 30 days, 0.1% year to date, 29.8% over 1 year and 63.3% over 5 years, which puts recent moves in a different context when lined up against the longer track record. Recent headlines around large U.S. banks have focused on...

Enterprise Products Partners (EPD) is back in focus after reporting record Q1 2026 operating volumes across key midstream segments, supported by strong distributable cash flow, ongoing distribution growth, and continued unit repurchases. See our latest analysis for Enterprise Products Partners. At a share price of $37.25, Enterprise Products Partners has eased slightly over the past week and month yet still carries a strong year to date share price return of 15.83% alongside a 1 year total...

Lovesac (LOVE) has opened Q1 2027 with revenue of US$138.2 million and a loss per share of US$0.76, setting a cautious tone after a profitable Q4 2026. Over recent quarters, revenue has moved between US$138.2 million and US$248.0 million while EPS has swung from a profit of about US$2.19 in Q4 2026 to losses in several other periods. This leaves you with a story of solid sales volumes but uneven profitability. For investors, the key takeaway is that margins remain tight, so the focus now is...

Tariffs are back in the headlines, and that matters for your portfolio. With a 10% global tariff still in force and legal fights dragging on, some US exporters look better placed than others, especially those that rely less on imported inputs and sit on solid balance sheets. This article focuses on large, financially robust companies that could be relatively more resilient if trade tensions persist. Below, you will find 3 stocks from a US Tariff-Resilient Exporters screener that appear...

Huntington Bancshares recently updated investors on its Texas bank acquisitions, reporting US$70 million of realized cost savings from Veritex and outlining a path to US$500 million in total cost and revenue synergies by the end of 2026, alongside longer-term earnings and return targets shared at a major financial conference. This integration update offers a clearer view of how Huntington aims to reshape its cost base and earnings mix through the Texas expansion and related efficiency...

Wondering if AMETEK at about US$227 per share offers fair value or if the price has run ahead of itself? This article looks at what the current valuation is really telling you. Over the short term the stock is up 0.3% over the last week, while the last month shows a 1.9% decline, and year to date the return stands at 8.6% with a 29.0% return over the past year and 48.3% and 79.3% over the last 3 and 5 years respectively. Recent coverage around AMETEK has focused on its role in the broader...

InterDigital stock snapshot after recent trading move InterDigital (IDCC) has drawn investor interest after a recent move in its share price, with the stock closing at $283.73. This comes alongside revenue of $828.924m and net income of $366.371m. See our latest analysis for InterDigital. The recent 1-day share price return of 2.56% and 7-day gain of 8.86% come after a tougher stretch, with the 90-day share price return down 20.98% even as the 5-year total shareholder return is nearly 3x. If...

Why Novanta Stock Is Drawing Attention Now Novanta (NOVT) is back on many watchlists after recent trading left the stock around $160.53, with returns over the past month and past 3 months standing out against longer term performance. See our latest analysis for Novanta. The recent share price of $160.53 comes after a strong 90 day share price return of 37.49% and a year to date share price return of 44.44%. However, the 3 year total shareholder return is slightly down 5.36%, which suggests...

For investors wondering whether UMB Financial at US$135.37 is still offering value or if most of the easy gains are already behind it, this article walks through what the current price might be implying. The stock shows returns of 4.2% over the last 7 days, 7.1% over the last 30 days, 16.2% year to date, 36.3% over 1 year, 125.3% over 3 years, and 66.3% over 5 years. These figures give useful context before assessing what the current valuation might suggest. Recent coverage of UMB Financial...

Recent commentary highlights that Iron Mountain’s data center and asset lifecycle management businesses delivered strong growth in 2025, reinforcing its position as a REIT focused on both physical and digital infrastructure. This combination of expanding digital infrastructure services and a consistently growing dividend profile is drawing renewed investor attention to Iron Mountain’s hybrid storage and information management model. We’ll now explore how this stronger momentum in Iron...

In early June 2026, Fluence Energy reported that independent assessor DNV validated 99.3% availability across its large-scale battery energy storage fleet and published a new Sustainability Report highlighting progress on environmental and governance goals. The company also earned recognition as the most sustainable corporation in the U.S. and among the top five globally, underscoring how operational reliability and sustainability credentials are becoming central to its position in the...

Wondering if Strategy at US$123.97 is priced for a turnaround or still carrying too much past hype? This article focuses squarely on what the numbers suggest about value. The stock has risen 2.9% over the last 7 days, but is down 30.4% over the past month and down 21.1% year to date, after a 67.6% decline over the past year and a very large gain of about 3x over three years. Recent coverage has highlighted Strategy as a high profile software stock that has attracted attention for its...

Barrick Mining (NYSE:B) reported a 60% reduction in injury rates since 2020. The company recorded a 28% year over year drop in lost time injuries. Barrick highlighted high levels of local hiring, strong procurement from local suppliers, and major community investments. For investors who have been focused on Barrick Mining’s recent share price swings, the latest update on safety and community impact adds another dimension to the NYSE:B story. The stock last closed at $40.2, with a return of...

Guardant Health (GH) is back in focus after the U.S. FDA approved its Guardant360 CDx liquid biopsy as a companion diagnostic for Boehringer Ingelheim’s HERNEXEOS in HER2 mutant advanced non small cell lung cancer. See our latest analysis for Guardant Health. The FDA decision appears to have arrived on top of already strong momentum, with a 30 day share price return of 33.67% and a 1 year total shareholder return of 167.03%, suggesting sentiment has shifted rapidly in Guardant Health’s...

What Matador Resources stock’s recent move might mean for you Matador Resources (MTDR) has seen mixed performance recently, with the stock up year to date but down over the past month and past 3 months, which naturally raises valuation questions for investors. See our latest analysis for Matador Resources. At a share price of $54.05, Matador’s recent 1 day and 7 day share price gains sit against weaker 30 day and 90 day share price returns and a stronger year to date share price return of...

This article examines whether Teladoc Health at US$7.34 is starting to look cheap or still carries more risk than reward, by breaking down what the current price might be implying about the stock. The share price has moved 4.1% over the last week and 8.1% over the last month, with a 4.1% return year to date. The return over 1 year sits at 7.0%, while the stock has fallen 70.5% over 3 years and 95.3% over 5 years. Recent news coverage has focused on Teladoc Health's role in telehealth and...

Why Camtek’s latest AI orders matter for investors Camtek (NasdaqGM:CAMT) has attracted fresh attention after announcing a multi system order worth $55 million from a tier 1 outsourced semiconductor assembly and test provider focused on AI applications. The company also reported more than $50 million in Hawk system orders from a high bandwidth memory customer for AI related uses, with all systems scheduled for delivery in 2027. See our latest analysis for Camtek. These AI focused orders have...

Wondering whether MasTec at around US$362.97 is still good value after a strong run, or if the easy gains are behind it? This article breaks down what the current price really reflects. The stock has had a mixed short term patch, with the price down 0.3% over the last week and down 14.4% over the last month, yet still up 59.4% year to date and 123.9% over the past year. Recent headlines have focused on MasTec's role in large scale infrastructure and energy transition projects, which has kept...

If you are wondering whether Amgen at around US$355 per share is offering fair value or not, the starting point is to understand what the current price is actually baking in. Over shorter periods, the stock has returned 1.6% over the last week, 5.6% over the last month, 8.4% year to date and 23.9% over the past year, with longer term returns of 69.6% over three years and 74.2% over five years. This hints that the market narrative around the stock has shifted over time. Recent headlines have...